Full name : Farlow Martin R
First name : Martin R
Mail : Department of Neurology, Alzheimer's Disease and Memory Disorders Center, Baylor College of Medicine, Houston, TX 07730
Zip Code :
City :
Country : USA
Email :
Phone :
Fax :
Website :
Directory :
| Title : Revisiting the Cholinergic Hypothesis in Alzheimer's Disease: Emerging Evidence from Translational and Clinical Research - Hampel_2019_J.Prev.Alzheimers.Dis_6_2 |
| Author(s) : Hampel H , Mesulam MM , Cuello AC , Khachaturian AS , Vergallo A , Farlow MR , Snyder PJ , Giacobini E , Khachaturian ZS |
| Ref : J Prev Alzheimers Dis , 6 :2 , 2019 |
| Abstract : Hampel_2019_J.Prev.Alzheimers.Dis_6_2 |
| ESTHER : Hampel_2019_J.Prev.Alzheimers.Dis_6_2 |
| PubMedSearch : Hampel_2019_J.Prev.Alzheimers.Dis_6_2 |
| PubMedID: 30569080 |
| Title : The cholinergic system in the pathophysiology and treatment of Alzheimer's disease - Hampel_2018_Brain_141_1917 |
| Author(s) : Hampel H , Mesulam MM , Cuello AC , Farlow MR , Giacobini E , Grossberg GT , Khachaturian AS , Vergallo A , Cavedo E , Snyder PJ , Khachaturian ZS |
| Ref : Brain , 141 :1917 , 2018 |
| Abstract : Hampel_2018_Brain_141_1917 |
| ESTHER : Hampel_2018_Brain_141_1917 |
| PubMedSearch : Hampel_2018_Brain_141_1917 |
| PubMedID: 29850777 |
| Title : Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease - Chase_2017_Neurotherapeutics_14_405 |
| Author(s) : Chase TN , Farlow MR , Clarence-Smith K |
| Ref : Neurotherapeutics , 14 :405 , 2017 |
| Abstract : Chase_2017_Neurotherapeutics_14_405 |
| ESTHER : Chase_2017_Neurotherapeutics_14_405 |
| PubMedSearch : Chase_2017_Neurotherapeutics_14_405 |
| PubMedID: 28138837 |
| Title : Reviewing the role of donepezil in the treatment of Alzheimer's disease - Doody_2012_Curr.Alzheimer.Res_9_773 |
| Author(s) : Doody RS , Cummings JL , Farlow MR |
| Ref : Curr Alzheimer Res , 9 :773 , 2012 |
| Abstract : Doody_2012_Curr.Alzheimer.Res_9_773 |
| ESTHER : Doody_2012_Curr.Alzheimer.Res_9_773 |
| PubMedSearch : Doody_2012_Curr.Alzheimer.Res_9_773 |
| PubMedID: 22175653 |
| Title : Rivastigmine transdermal patch and capsule in Alzheimer's disease: influence of disease stage on response to therapy - Farlow_2011_Int.J.Geriatr.Psychiatry_26_1236 |
| Author(s) : Farlow MR , Grossberg GT , Meng X , Olin J , Somogyi M |
| Ref : Int J Geriatr Psychiatry , 26 :1236 , 2011 |
| Abstract : Farlow_2011_Int.J.Geriatr.Psychiatry_26_1236 |
| ESTHER : Farlow_2011_Int.J.Geriatr.Psychiatry_26_1236 |
| PubMedSearch : Farlow_2011_Int.J.Geriatr.Psychiatry_26_1236 |
| PubMedID: 22068922 |
| Title : Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease - Farlow_2010_Am.J.Alzheimers.Dis.Other.Demen_25_347 |
| Author(s) : Farlow MR , Cummings JL , Olin JT , Meng X |
| Ref : Am J Alzheimers Dis Other Demen , 25 :347 , 2010 |
| Abstract : Farlow_2010_Am.J.Alzheimers.Dis.Other.Demen_25_347 |
| ESTHER : Farlow_2010_Am.J.Alzheimers.Dis.Other.Demen_25_347 |
| PubMedSearch : Farlow_2010_Am.J.Alzheimers.Dis.Other.Demen_25_347 |
| PubMedID: 20392862 |
| Title : Differences in medication use in the Alzheimer's disease neuroimaging initiative: analysis of baseline characteristics - Epstein_2010_Drugs.Aging_27_677 |
| Author(s) : Epstein NU , Saykin AJ , Risacher SL , Gao S , Farlow MR |
| Ref : Drugs & Aging , 27 :677 , 2010 |
| Abstract : Epstein_2010_Drugs.Aging_27_677 |
| ESTHER : Epstein_2010_Drugs.Aging_27_677 |
| PubMedSearch : Epstein_2010_Drugs.Aging_27_677 |
| PubMedID: 20658795 |
| Title : Treatment options in Alzheimer's disease: maximizing benefit, managing expectations - Farlow_2008_Dement.Geriatr.Cogn.Disord_25_408 |
| Author(s) : Farlow MR , Miller ML , Pejovic V |
| Ref : Dementia & Geriatric Cognitive Disorders , 25 :408 , 2008 |
| Abstract : Farlow_2008_Dement.Geriatr.Cogn.Disord_25_408 |
| ESTHER : Farlow_2008_Dement.Geriatr.Cogn.Disord_25_408 |
| PubMedSearch : Farlow_2008_Dement.Geriatr.Cogn.Disord_25_408 |
| PubMedID: 18391487 |
| Title : Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease - Lane_2008_Pharmacogenet.Genomics_18_289 |
| Author(s) : Lane R , Feldman HH , Meyer J , He Y , Ferris SH , Nordberg A , Darreh-Shori T , Soininen H , Pirttila T , Farlow MR , Sfikas N , Ballard C , Greig NH |
| Ref : Pharmacogenet Genomics , 18 :289 , 2008 |
| Abstract : Lane_2008_Pharmacogenet.Genomics_18_289 |
| ESTHER : Lane_2008_Pharmacogenet.Genomics_18_289 |
| PubMedSearch : Lane_2008_Pharmacogenet.Genomics_18_289 |
| PubMedID: 18334913 |
| Title : Effective pharmacologic management of Alzheimer's disease - Farlow_2007_Am.J.Med_120_388 |
| Author(s) : Farlow MR , Cummings JL |
| Ref : American Journal of Medicine , 120 :388 , 2007 |
| Abstract : Farlow_2007_Am.J.Med_120_388 |
| ESTHER : Farlow_2007_Am.J.Med_120_388 |
| PubMedSearch : Farlow_2007_Am.J.Med_120_388 |
| PubMedID: 17466645 |
| Title : Use of antidementia agents in vascular dementia: beyond Alzheimer disease - Farlow_2006_Mayo.Clin.Proc_81_1350 |
| Author(s) : Farlow MR |
| Ref : Mayo Clin Proc , 81 :1350 , 2006 |
| Abstract : Farlow_2006_Mayo.Clin.Proc_81_1350 |
| ESTHER : Farlow_2006_Mayo.Clin.Proc_81_1350 |
| PubMedSearch : Farlow_2006_Mayo.Clin.Proc_81_1350 |
| PubMedID: 17036561 |
| Title : Recommendations for best practices in the treatment of Alzheimer's disease in managed care - Fillit_2006_Am.J.Geriatr.Pharmacother_4 Suppl A_S9 |
| Author(s) : Fillit HM , Doody RS , Binaso K , Crooks GM , Ferris SH , Farlow MR , Leifer B , Mills C , Minkoff N , Orland B , Reichman WE , Salloway S |
| Ref : Am J Geriatr Pharmacother , 4 Suppl A :S9 , 2006 |
| Abstract : Fillit_2006_Am.J.Geriatr.Pharmacother_4 Suppl A_S9 |
| ESTHER : Fillit_2006_Am.J.Geriatr.Pharmacother_4 Suppl A_S9 |
| PubMedSearch : Fillit_2006_Am.J.Geriatr.Pharmacother_4 Suppl A_S9 |
| PubMedID: 17157793 |
| Title : High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression - Sokol_2006_J.Child.Neurol_21_444 |
| Author(s) : Sokol DK , Chen D , Farlow MR , Dunn DW , Maloney B , Zimmer JA , Lahiri DK |
| Ref : Journal of Child Neurology , 21 :444 , 2006 |
| Abstract : Sokol_2006_J.Child.Neurol_21_444 |
| ESTHER : Sokol_2006_J.Child.Neurol_21_444 |
| PubMedSearch : Sokol_2006_J.Child.Neurol_21_444 |
| PubMedID: 16948926 |
| Title : Switching From Donepezil to Rivastigmine Is Well Tolerated: Results of an Open-Label Safety and Tolerability Study - Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43 |
| Author(s) : Sadowsky CH , Farlow MR , Atkinson L , Steadman J , Koumaras B , Chen M , Mirski D |
| Ref : Prim Care Companion J Clin Psychiatry , 7 :43 , 2005 |
| Abstract : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43 |
| ESTHER : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43 |
| PubMedSearch : Sadowsky_2005_Prim.Care.Companion.J.Clin.Psychiatry_7_43 |
| PubMedID: 15841194 |
| Title : Rivastigmine: an open-label, observational study of safety and effectiveness in treating patients with Alzheimer's disease for up to 5 years - Farlow_2005_BMC.Geriatr_5_3 |
| Author(s) : Farlow MR , Lilly ML |
| Ref : BMC Geriatr , 5 :3 , 2005 |
| Abstract : Farlow_2005_BMC.Geriatr_5_3 |
| ESTHER : Farlow_2005_BMC.Geriatr_5_3 |
| PubMedSearch : Farlow_2005_BMC.Geriatr_5_3 |
| PubMedID: 15659242 |
| Title : Efficacy of rivastigmine in Alzheimer's disease patients with rapid disease progression: results of a meta-analysis - Farlow_2005_Dement.Geriatr.Cogn.Disord_20_192 |
| Author(s) : Farlow MR , Small GW , Quarg P , Krause A |
| Ref : Dementia & Geriatric Cognitive Disorders , 20 :192 , 2005 |
| Abstract : Farlow_2005_Dement.Geriatr.Cogn.Disord_20_192 |
| ESTHER : Farlow_2005_Dement.Geriatr.Cogn.Disord_20_192 |
| PubMedSearch : Farlow_2005_Dement.Geriatr.Cogn.Disord_20_192 |
| PubMedID: 16088144 |
| Title : The use of memantine in dementia with Lewy bodies - Sabbagh_2005_J.Alzheimers.Dis_7_285 |
| Author(s) : Sabbagh MN , Hake AM , Ahmed S , Farlow MR |
| Ref : J Alzheimers Dis , 7 :285 , 2005 |
| Abstract : Sabbagh_2005_J.Alzheimers.Dis_7_285 |
| ESTHER : Sabbagh_2005_J.Alzheimers.Dis_7_285 |
| PubMedSearch : Sabbagh_2005_J.Alzheimers.Dis_7_285 |
| PubMedID: 16131729 |
| Title : Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease - Lane_2005_J.Lipid.Res_46_949 |
| Author(s) : Lane RM , Farlow MR |
| Ref : J Lipid Res , 46 :949 , 2005 |
| Abstract : Lane_2005_J.Lipid.Res_46_949 |
| ESTHER : Lane_2005_J.Lipid.Res_46_949 |
| PubMedSearch : Lane_2005_J.Lipid.Res_46_949 |
| PubMedID: 15716586 |
| Title : Cholinesterase inhibitors across stages of dementia and cognitive impairments in the elderly - Grossberg_2005_CNS.Spectr_10_1 |
| Author(s) : Grossberg GT , Borson S , Kaufer DI , Farlow MR |
| Ref : CNS Spectr , 10 :1 , 2005 |
| Abstract : Grossberg_2005_CNS.Spectr_10_1 |
| ESTHER : Grossberg_2005_CNS.Spectr_10_1 |
| PubMedSearch : Grossberg_2005_CNS.Spectr_10_1 |
| PubMedID: 15980818 |
| Title : Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial - Tariot_2004_JAMA_291_317 |
| Author(s) : Tariot PN , Farlow MR , Grossberg GT , Graham SM , McDonald S , Gergel I |
| Ref : Jama , 291 :317 , 2004 |
| Abstract : Tariot_2004_JAMA_291_317 |
| ESTHER : Tariot_2004_JAMA_291_317 |
| PubMedSearch : Tariot_2004_JAMA_291_317 |
| PubMedID: 14734594 |
| Title : Poster (39) A new generation of cholinesterase inhibitors with amyloid-modifying properties. - |
| Author(s) : Lahiri DK , Ge YW , Sambamurti K , Utsuki T , Ingram DK , Farlow MR , Greig NH |
| Ref : In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects , (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina :341 , 2004 |
| PubMedID: |
| Title : Utilizing combination therapy in the treatment of Alzheimer's disease - Farlow_2004_Expert.Rev.Neurother_4_799 |
| Author(s) : Farlow MR |
| Ref : Expert Rev Neurother , 4 :799 , 2004 |
| Abstract : Farlow_2004_Expert.Rev.Neurother_4_799 |
| ESTHER : Farlow_2004_Expert.Rev.Neurother_4_799 |
| PubMedSearch : Farlow_2004_Expert.Rev.Neurother_4_799 |
| PubMedID: 15853507 |
| Title : Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial - Aisen_2003_JAMA_289_2819 |
| Author(s) : Aisen PS , Schafer KA , Grundman M , Pfeiffer E , Sano M , Davis KL , Farlow MR , Jin S , Thomas RG , Thal LJ |
| Ref : Jama , 289 :2819 , 2003 |
| Abstract : Aisen_2003_JAMA_289_2819 |
| ESTHER : Aisen_2003_JAMA_289_2819 |
| PubMedSearch : Aisen_2003_JAMA_289_2819 |
| PubMedID: 12783912 |
| Title : Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors - Gauthier_2003_Curr.Med.Res.Opin_19_707 |
| Author(s) : Gauthier S , Emre M , Farlow MR , Bullock R , Grossberg GT , Potkin SG |
| Ref : Curr Med Res Opin , 19 :707 , 2003 |
| Abstract : Gauthier_2003_Curr.Med.Res.Opin_19_707 |
| ESTHER : Gauthier_2003_Curr.Med.Res.Opin_19_707 |
| PubMedSearch : Gauthier_2003_Curr.Med.Res.Opin_19_707 |
| PubMedID: 14687441 |
| Title : Clinical pharmacokinetics of galantamine - Farlow_2003_Clin.Pharmacokinet_42_1383 |
| Author(s) : Farlow MR |
| Ref : Clinical Pharmacokinetics , 42 :1383 , 2003 |
| Abstract : Farlow_2003_Clin.Pharmacokinet_42_1383 |
| ESTHER : Farlow_2003_Clin.Pharmacokinet_42_1383 |
| PubMedSearch : Farlow_2003_Clin.Pharmacokinet_42_1383 |
| PubMedID: 14674789 |
| Title : Update on rivastigmine - Farlow_2003_Neurologist_9_230 |
| Author(s) : Farlow MR |
| Ref : Neurologist , 9 :230 , 2003 |
| Abstract : Farlow_2003_Neurologist_9_230 |
| ESTHER : Farlow_2003_Neurologist_9_230 |
| PubMedSearch : Farlow_2003_Neurologist_9_230 |
| PubMedID: 14587496 |
| Title : A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease - Lahiri_2003_Curr.Drug.Targets_4_97 |
| Author(s) : Lahiri DK , Farlow MR , Sambamurti K , Greig NH , Giacobini E , Schneider LS |
| Ref : Curr Drug Targets , 4 :97 , 2003 |
| Abstract : Lahiri_2003_Curr.Drug.Targets_4_97 |
| ESTHER : Lahiri_2003_Curr.Drug.Targets_4_97 |
| PubMedSearch : Lahiri_2003_Curr.Drug.Targets_4_97 |
| PubMedID: 12558063 |
| Title : Nicotine reduces the secretion of Alzheimer's beta-amyloid precursor protein containing beta-amyloid peptide in the rat without altering synaptic proteins - Lahiri_2002_Ann.N.Y.Acad.Sci_965_364 |
| Author(s) : Lahiri DK , Utsuki T , Chen D , Farlow MR , Shoaib M , Ingram DK , Greig NH |
| Ref : Annals of the New York Academy of Sciences , 965 :364 , 2002 |
| Abstract : Lahiri_2002_Ann.N.Y.Acad.Sci_965_364 |
| ESTHER : Lahiri_2002_Ann.N.Y.Acad.Sci_965_364 |
| PubMedSearch : Lahiri_2002_Ann.N.Y.Acad.Sci_965_364 |
| PubMedID: 12105112 |
| Title : Do cholinesterase inhibitors slow progression of Alzheimer's disease? - Farlow_2002_Int.J.Clin.Pract.Suppl_127_37 |
| Author(s) : Farlow MR |
| Ref : Int J Clin Pract Suppl , 127 :37 , 2002 |
| Abstract : Farlow_2002_Int.J.Clin.Pract.Suppl_127_37 |
| ESTHER : Farlow_2002_Int.J.Clin.Pract.Suppl_127_37 |
| PubMedSearch : Farlow_2002_Int.J.Clin.Pract.Suppl_127_37 |
| PubMedID: 12139366 |
| Title : Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamine - Farlow_2001_Clin.Ther_23 Suppl A_A13 |
| Author(s) : Farlow MR |
| Ref : Clin Ther , 23 Suppl A :A13 , 2001 |
| Abstract : Farlow_2001_Clin.Ther_23 Suppl A_A13 |
| ESTHER : Farlow_2001_Clin.Ther_23 Suppl A_A13 |
| PubMedSearch : Farlow_2001_Clin.Ther_23 Suppl A_A13 |
| PubMedID: 11396867 |
| Title : New concepts in the drug therapy of Alzheimer's disease - Hake_2001_Expert.Opin.Pharmacother_2_1975 |
| Author(s) : Hake AM , Farlow MR |
| Ref : Expert Opin Pharmacother , 2 :1975 , 2001 |
| Abstract : Hake_2001_Expert.Opin.Pharmacother_2_1975 |
| ESTHER : Hake_2001_Expert.Opin.Pharmacother_2_1975 |
| PubMedSearch : Hake_2001_Expert.Opin.Pharmacother_2_1975 |
| PubMedID: 11825329 |
| Title : Response of patients with Alzheimer disease to rivastigmine treatment is predicted by the rate of disease progression - Farlow_2001_Arch.Neurol_58_417 |
| Author(s) : Farlow MR , Hake A , Messina J , Hartman R , Veach J , Anand R |
| Ref : Archives of Neurology , 58 :417 , 2001 |
| Abstract : Farlow_2001_Arch.Neurol_58_417 |
| ESTHER : Farlow_2001_Arch.Neurol_58_417 |
| PubMedSearch : Farlow_2001_Arch.Neurol_58_417 |
| PubMedID: 11255445 |
| Title : Cholinesterase inhibitors, beta-amyloid precursor protein and amyloid beta-peptides in Alzheimer's disease - Lahiri_2000_Acta.Neurol.Scand.Suppl_176_60 |
| Author(s) : Lahiri DK , Farlow MR , Hintz N , Utsuki T , Greig NH |
| Ref : Acta Neurologica Scandinavica Supplementum , 176 :60 , 2000 |
| Abstract : Lahiri_2000_Acta.Neurol.Scand.Suppl_176_60 |
| ESTHER : Lahiri_2000_Acta.Neurol.Scand.Suppl_176_60 |
| PubMedSearch : Lahiri_2000_Acta.Neurol.Scand.Suppl_176_60 |
| PubMedID: 11273593 |
| Title : Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials - Farlow_2000_Dement.Geriatr.Cogn.Disord_11_202 |
| Author(s) : Farlow MR , Cyrus PA |
| Ref : Dementia & Geriatric Cognitive Disorders , 11 :202 , 2000 |
| Abstract : Farlow_2000_Dement.Geriatr.Cogn.Disord_11_202 |
| ESTHER : Farlow_2000_Dement.Geriatr.Cogn.Disord_11_202 |
| PubMedSearch : Farlow_2000_Dement.Geriatr.Cogn.Disord_11_202 |
| PubMedID: 10867446 |
| Title : Metrifonate treatment of AD: influence of APOE genotype - Farlow_1999_Neurology_53_2010 |
| Author(s) : Farlow MR , Cyrus PA , Nadel A , Lahiri DK , Brashear A , Gulanski B |
| Ref : Neurology , 53 :2010 , 1999 |
| Abstract : Farlow_1999_Neurology_53_2010 |
| ESTHER : Farlow_1999_Neurology_53_2010 |
| PubMedSearch : Farlow_1999_Neurology_53_2010 |
| PubMedID: 10599773 |
| Title : A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group - Rogers_1998_Neurology_50_136 |
| Author(s) : Rogers SL , Farlow MR , Doody RS , Mohs R , Friedhoff LT |
| Ref : Neurology , 50 :136 , 1998 |
| Abstract : Rogers_1998_Neurology_50_136 |
| ESTHER : Rogers_1998_Neurology_50_136 |
| PubMedSearch : Rogers_1998_Neurology_50_136 |
| PubMedID: 9443470 |
| Title : The secretion of amyloid beta-peptides is inhibited in the tacrine-treated human neuroblastoma cells - Lahiri_1998_Brain.Res.Mol.Brain.Res_62_131 |
| Author(s) : Lahiri DK , Farlow MR , Sambamurti K |
| Ref : Brain Research Mol Brain Res , 62 :131 , 1998 |
| Abstract : Lahiri_1998_Brain.Res.Mol.Brain.Res_62_131 |
| ESTHER : Lahiri_1998_Brain.Res.Mol.Brain.Res_62_131 |
| PubMedSearch : Lahiri_1998_Brain.Res.Mol.Brain.Res_62_131 |
| PubMedID: 9813282 |
| Title : Pharmacologic treatment of cognition in Alzheimer's dementia - Farlow_1998_Neurology_51_S65 |
| Author(s) : Farlow MR , Evans RM |
| Ref : Neurology , 51 :S65 , 1998 |
| Abstract : Farlow_1998_Neurology_51_S65 |
| ESTHER : Farlow_1998_Neurology_51_S65 |
| PubMedSearch : Farlow_1998_Neurology_51_S65 |
| PubMedID: 9674761 |
| Title : Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease - Farlow_1998_Neurology_50_669 |
| Author(s) : Farlow MR , Lahiri DK , Poirier J , Davignon J , Schneider L , Hui SL |
| Ref : Neurology , 50 :669 , 1998 |
| Abstract : Farlow_1998_Neurology_50_669 |
| ESTHER : Farlow_1998_Neurology_50_669 |
| PubMedSearch : Farlow_1998_Neurology_50_669 |
| PubMedID: 9521254 |
| Title : Effects of cholinesterase inhibitors on the secretion of beta-amyloid precursor protein in cell cultures - Lahiri_1997_Ann.N.Y.Acad.Sci_826_416 |
| Author(s) : Lahiri DK , Farlow MR , Nurnberger JI, Jr. , Greig NH |
| Ref : Annals of the New York Academy of Sciences , 826 :416 , 1997 |
| Abstract : Lahiri_1997_Ann.N.Y.Acad.Sci_826_416 |
| ESTHER : Lahiri_1997_Ann.N.Y.Acad.Sci_826_416 |
| PubMedSearch : Lahiri_1997_Ann.N.Y.Acad.Sci_826_416 |
| PubMedID: 9329715 |
| Title : Potential role for estrogen replacement in the treatment of Alzheimer's dementia - Schneider_1997_Am.J.Med_103_46S |
| Author(s) : Schneider LS , Farlow MR , Pogoda JM |
| Ref : American Journal of Medicine , 103 :46S , 1997 |
| Abstract : Schneider_1997_Am.J.Med_103_46S |
| ESTHER : Schneider_1997_Am.J.Med_103_46S |
| PubMedSearch : Schneider_1997_Am.J.Med_103_46S |
| PubMedID: 9344406 |
| Title : The effect of tacrine and leupeptin on the secretion of the beta- amyloid precursor protein in HeLa cells - Lahiri_1997_Life.Sci_61_1985 |
| Author(s) : Lahiri DK , Farlow MR , Sambamurti K , Nall C |
| Ref : Life Sciences , 61 :1985 , 1997 |
| Abstract : Lahiri_1997_Life.Sci_61_1985 |
| ESTHER : Lahiri_1997_Life.Sci_61_1985 |
| PubMedSearch : Lahiri_1997_Life.Sci_61_1985 |
| PubMedID: 9366505 |
| Title : Apolipoprotein E genotype and gender influence response to tacrine therapy - Farlow_1996_Ann.N.Y.Acad.Sci_802_101 |
| Author(s) : Farlow MR , Lahiri DK , Poirier J , Davignon J , Hui S |
| Ref : Annals of the New York Academy of Sciences , 802 :101 , 1996 |
| Abstract : Farlow_1996_Ann.N.Y.Acad.Sci_802_101 |
| ESTHER : Farlow_1996_Ann.N.Y.Acad.Sci_802_101 |
| PubMedSearch : Farlow_1996_Ann.N.Y.Acad.Sci_802_101 |
| PubMedID: 8993489 |
| Title : Differential effect of tacrine and physostigmine on the secretion of the beta-amyloid precursor protein in cell lines - Lahiri_1996_J.Mol.Neurosci_7_41 |
| Author(s) : Lahiri DK , Farlow MR |
| Ref : Journal of Molecular Neuroscience , 7 :41 , 1996 |
| Abstract : Lahiri_1996_J.Mol.Neurosci_7_41 |
| ESTHER : Lahiri_1996_J.Mol.Neurosci_7_41 |
| PubMedSearch : Lahiri_1996_J.Mol.Neurosci_7_41 |
| PubMedID: 8835781 |
| Title : Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer's disease - Schneider_1996_Neurology_46_1580 |
| Author(s) : Schneider LS , Farlow MR , Henderson VW , Pogoda JM |
| Ref : Neurology , 46 :1580 , 1996 |
| Abstract : Schneider_1996_Neurology_46_1580 |
| ESTHER : Schneider_1996_Neurology_46_1580 |
| PubMedSearch : Schneider_1996_Neurology_46_1580 |
| PubMedID: 8649552 |
| Title : Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines - Lahiri_1994_J.Neurosci.Res_37_777 |
| Author(s) : Lahiri DK , Lewis S , Farlow MR |
| Ref : Journal of Neuroscience Research , 37 :777 , 1994 |
| Abstract : Lahiri_1994_J.Neurosci.Res_37_777 |
| ESTHER : Lahiri_1994_J.Neurosci.Res_37_777 |
| PubMedSearch : Lahiri_1994_J.Neurosci.Res_37_777 |
| PubMedID: 8046778 |